Related Experiment Video
Updated: Jun 29, 2026

Quantification of Oculomotor Responses and Accommodation Through Instrumentation and Analysis Toolboxes
Published on: March 3, 2023
Randomized clinical trial of treatments for symptomatic convergence insufficiency in children
Insights
Office-based vergence therapy significantly improved convergence insufficiency symptoms in children. This treatment showed superior results compared to home-based therapies and placebo over 12 weeks.
Area of Science:
- Ophthalmology
- Pediatric Optometry
- Vision Therapy
Background:
- Symptomatic convergence insufficiency (CI) is a common condition affecting children's visual function.
- Current treatments vary in approach and efficacy, necessitating comparative studies.
Purpose of the Study:
- To compare the effectiveness of four treatment protocols for symptomatic convergence insufficiency in children.
- Evaluate home-based pencil push-ups (HBPP), home-based computer vergence/accommodative therapy with pencil push-ups (HBCVAT+), office-based vergence/accommodative therapy with home reinforcement (OBVAT), and office-based placebo therapy with home reinforcement (OBPT).
Main Methods:
- A randomized clinical trial involving 221 children aged 9-17 years with symptomatic CI.
- Participants were assigned to one of the four treatment groups for 12 weeks.
- Primary outcome measure was the Convergence Insufficiency Symptom Survey score; secondary measures included near point of convergence and positive fusional vergence.
Main Results:
- The OBVAT group showed a statistically significant lower mean Symptom Survey score (15.1) compared to HBCVAT+ (21.3), HBPP (24.7), and OBPT (21.9) (P < .001).
- OBVAT also resulted in significantly improved near point of convergence and positive fusional vergence compared to other groups (P <= .005).
- Success rates were highest in the OBVAT group (73%) compared to HBPP (43%), HBCVAT+ (33%), and OBPT (35%).
Conclusions:
- Twelve weeks of office-based vergence accommodative therapy (OBVAT) with home reinforcement is significantly more effective than HBPP, HBCVAT+, and OBPT for treating symptomatic convergence insufficiency in children.
- OBVAT leads to greater symptom improvement and better clinical outcomes in near point of convergence and positive fusional vergence.
- Office-based vergence accommodative therapy is an effective clinical treatment for pediatric symptomatic convergence insufficiency.
Objective:
To compare home-based pencil push-ups (HBPP), home-based computer vergence/accommodative therapy and pencil push-ups (HBCVAT+), office-based vergence/accommodative therapy with home reinforcement (OBVAT), and office-based placebo therapy with home reinforcement (OBPT) as treatments for symptomatic convergence insufficiency.
Methods:
In a randomized clinical trial, 221 children aged 9 to 17 years with symptomatic convergence insufficiency were assigned to 1 of 4 treatments.
Main Outcome Measures:
Convergence Insufficiency Symptom Survey score after 12 weeks of treatment. Secondary outcomes were near point of convergence and positive fusional vergence at near.
Results:
After 12 weeks of treatment, the OBVAT group's mean Convergence Insufficiency Symptom Survey score (15.1) was statistically significantly lower than those of 21.3, 24.7, and 21.9 in the HBCVAT+, HBPP, and OBPT groups, respectively (P < .001). The OBVAT group also demonstrated a significantly improved near point of convergence and positive fusional vergence at near compared with the other groups (P
Conclusions:
Twelve weeks of OBVAT results in a significantly greater improvement in symptoms and clinical measures of near point of convergence and positive fusional vergence and a greater percentage of patients reaching the predetermined criteria of success compared with HBPP, HBCVAT+, and OBPT. Application to Clinical Practice Office-based vergence accommodative therapy is an effective treatment for children with symptomatic convergence insufficiency.
Trial Registration:
clinicaltrials.gov Identifier: NCT00338611.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Mitral Stenosis II: Clinical features and Diagnostic Tests
Angle Closure Glaucoma: Treatment
